vs
Side-by-side financial comparison of Prenetics Global Ltd (PRE) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
PRE
TXG
| Q3 23 | $4.3M | — | ||
| Q2 23 | $4.2M | — | ||
| Q1 23 | $92.0M | — | ||
| Q3 22 | $74.7M | — | ||
| Q1 22 | $57.5M | — |
Gross MarginPRETXG
| Q3 23 | 44.9% | — | ||
| Q2 23 | 32.5% | — | ||
| Q1 23 | 39.2% | — | ||
| Q3 22 | 34.5% | — | ||
| Q1 22 | 38.2% | — |
Operating MarginPRETXG
| Q3 23 | -396.2% | — | ||
| Q2 23 | -544.7% | — | ||
| Q1 23 | — | — | ||
| Q3 22 | -7.2% | — | ||
| Q1 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
